Sodium Bicarbonate for the Prevention of Contrast Induced-Acute Kidney Injury: A Systematic Review and Meta-analysis

被引:110
作者
Brar, Somjot S. [1 ]
Hirernath, Swapnil [2 ]
Dangas, George [1 ]
Mehran, Roxana [1 ]
Brar, Simerjeet K. [1 ]
Leon, Martin B. [1 ]
机构
[1] Columbia Univ, Med Ctr, Ctr Intervent Vasc Therapy, New York, NY 10032 USA
[2] Univ Ottawa, Kidney Res Ctr, Ottawa, ON, Canada
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2009年 / 4卷 / 10期
关键词
PERCUTANEOUS CORONARY INTERVENTION; RADIOCONTRAST-INDUCED NEPHROPATHY; RENAL-INSUFFICIENCY; CLINICAL-TRIALS; RANDOMIZED-TRIAL; N-ACETYLCYSTEINE; ANGIOGRAPHY; HYDRATION; CHLORIDE; SALINE;
D O I
10.2215/CJN.03120509
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Infusion of sodium bicarbonate has been suggested as a preventative strategy but reports are conflicting on its efficacy. The aim of this study was to assess the effectiveness of hydration with sodium bicarbonate for the prevention of contrast-induced acute kidney injury (CI-AKI). Design, setting, participants, & measurements: Medline, EMBASE, Cochrane library, and the Internet were searched for randomized controlled trials comparing hydration between sodium bicarbonate and chloride for the prevention of CI-AKI between 1966 and November 2008. Fourteen trials that included 2290 patients were identified. There was significant heterogeneity between studies (P heterogeneity = 0.02; I(2) = 47.8%), which was largely accounted for by trial size (P = 0.016). Trials were therefore classified by size. Results: Three trials were categorized as large (n = 1145) and 12 as small (n = 1145). Among the large trials, the incidence of CI-AKI for sodium bicarbonate and sodium chloride was 10.7 and 12.5%, respectively; the relative risk (RR) [95% confidence interval (CM was 0.85 (0.63 to 1.16) without evidence of heterogeneity (P = 0.89, I(2) = 0%). The pooled RR (95% CI) among the 12 small trials was 0.50 (0.27 to 0.93) with significant between-trial heterogeneity (P = 0.01; I(2) = 56%). The small trials were more likely to be of lower methodological quality. Conclusions: A significant clinical and statistical heterogeneity was observed that was largely explained by trial size and published status. Among the large randomized trials there was no evidence of benefit for hydration with sodium bicarbonate compared with sodium chloride for the prevention of CI-AKI. The benefit of sodium bicarbonate was limited to small trials of lower methodological quality. Clin J Am Soc Nephrol 4: 1584-1592, 2009. doi: 10.2215/CJN.03120509
引用
收藏
页码:1584 / 1592
页数:9
相关论文
共 37 条
[21]   Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement [J].
Moher, D ;
Cook, DJ ;
Eastwood, S ;
Olkin, I ;
Rennie, D ;
Stroup, DF .
LANCET, 1999, 354 (9193) :1896-1900
[22]   Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis [J].
Navaneethan, Sankar D. ;
Singh, Sonal ;
Appasamy, Suresh ;
Wing, Richard E. ;
Sehgal, Ashwini R. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) :617-627
[23]  
Nikolsky Eugenia, 2003, Rev Cardiovasc Med, V4 Suppl 1, pS7
[24]   Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy.: A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures.: A single-center prospective controlled trial [J].
Ozcan, Einin E. ;
Guneri, Seina ;
Akdeniz, Bahri ;
Akyildiz, Ilke Z. ;
Senaslan, Omer ;
Baris, Nezihi ;
Aslan, Ozgur ;
Badak, Ozer .
AMERICAN HEART JOURNAL, 2007, 154 (03) :539-544
[25]   The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention -: The RENO study [J].
Recio-Mayoral, Alejandro ;
Chaparro, Marinela ;
Prado, Belen ;
Cozar, Rocio ;
Mendez, Irene ;
Banerjee, Debasish ;
Kaski, Juan C. ;
Cubero, Jose ;
Cruz, Jose M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (12) :1283-1288
[26]  
Rudnick Michael R, 2003, Rev Cardiovasc Med, V4 Suppl 5, pS28
[27]  
SAIDIN R, 2006, J AM SOC NEPHROL, V17, pA766
[28]  
Shaikh F, 2007, AM J CARDIOL, V100, p122L
[29]  
Sharp SJ, 1996, BRIT MED J, V313, P735
[30]  
Shavit L, 2008, J AM SOC NEPHROL, V19, p787A